Skip to content
CDMO SERVICES FOR PROTEINS & ANTIBODIES

Developability Assessment

Are your selected lead candidates stable, soluble, and robust enough to make it to the clinic?

ProBioGen's developability assessment platform measures the molecular properties and stress responses that drive aggregation, particle formation and formulation risk—revealing your candidate’s comprehensive developability profile. Orthogonal data support candidate selection, identify critical liabilities, and help define the next development step before significant material, time, and resources are committed to advancing the candidate.

IN A NUTSHELL

De-Risk Your Lead Candidate With Early Insights

Developability failures often emerge during the purification, concentration, storage or handling of a biologic candidate, at a point when starting over is both costly and time-intensive. Our platform directly tests candidates under relevant solution and stress conditions, providing critical insights early and de-risking the path from candidate to clinic.

Conformational stability, colloidal stability, aggregation, fragmentation, charge heterogeneity, subvisible particles, solubility, self-interaction and viscosity are assessed using orthogonal methods. Forced degradation studies reveal sensitivity to temperature, agitation, freeze-thaw, oxidation and pH. For multiple candidates, predefined criteria enable transparent ranking. The result is a comprehensive experimental risk profile with clear recommendations for candidate selection, formulation work, and further development.

Icon-nutshel Developability Assessment
HOW WE WORK

 

Tailored to Your Molecule

Methods, stress conditions, and decision criteria are selected for the molecular format, development stage, intended product profile and available material.

 

From R&D to GMP

Developability assessments are performed in a controlled R&D environment using documented procedures. Methods and results can be transferred into ProBioGen's GMP analytical and stability workflows when required.

 

One-Stop-Shop

The assessment can be applied directly to formulation development, analytical development, bioassays, stability studies, process development and GMP manufacturing, all under one roof at ProBioGen.

 

Integrated Team Work

Biophysics, formulation, analytics, DSP and bioassay experts jointly define the study and interpret the complete dataset.
OUR CAPABILITIES

What We Offer

Baseline Physicochemical Characterization
Conformational and Colloidal Stability
Forced Degradation and Stress Testing
Aggregation and Particle Assessment
Solubility and High-Concentration Behavior
Early Formulation Assessment
Candidate Comparison and Ranking

Experimental Developability Workflow

Developability Assessment Process Graphic-3

Our Promise To You

Asset 14-1
 
Confidence in Candidate Decisions
  • Early visibility of critical developability liabilities
  • Transparent ranking across multiple candidates
Asset 28
 
Evidence Specific to Your Molecule
  • Study design matched to molecule, stage and product profile
  • Testing under relevant solution and stress conditions
Asset 14
 
 Clear Development Recommendations
  • Guidance for candidate selection and formulation strategy
  • Findings that inform further development decision

Elevate Your Candidate With The Right CDMO

Discover Related Services

Explore Protein Technologies

Explore Related Content

Project_Management_Meeting_color_cropped_small-1
­­The Hidden Hero of Drug Development: Project Management That Delivers

Blog Post

ProBioGen_Laboratory_Media_100px-1
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services

Press Release

How_to_Choose_the_right_CDMO_ProBioGen_Teammeeting_Small-1
How to Choose the Right CDMO Partner for Your Project

Blog Post

woman at sterile hood image
ProBioGen Successfully Completes CMC Development Milestones for Marea’s Promising Acromegaly Therapeutic

Press Release

Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.